טוען...
New horizons in ablation therapy for hepatocellular carcinoma
Historically ablative treatment for hepatocellular cancer (HCC) has been regarded as inferior to transplantation and resection and has therefore been reserved for patients not suitable for surgical intervention in stage 0-A HCC according to the Barcelona Clinic Liver Cancer classification system. In...
שמור ב:
| הוצא לאור ב: | Hepat Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Future Medicine Ltd
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095152/ https://ncbi.nlm.nih.gov/pubmed/30191017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.15.28 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|